Howard Rubin - Trupanion Independent Consultant
TRUP Stock | USD 36.78 0.89 2.36% |
Executive
Mr. Howard Rubin serves as Director of Trupanion, Inc., since March 2010. Mr. Rubin currently serves on the Deans Advisory Board for the College of Veterinary Medicine at Western University of Health Sciences, the Chief Executive Officer Advisory Committee of the Western Veterinary Conference and the American Veterinary Medical Association Insurance Trust Governance Task Force. Mr. Rubin previously served as our Chief Operating Officer from March 2010 to May 2014, and as our Secretary from July 2012 to August 2013. Mr. Rubin founded and served as Chief Executive Officer at BrightHeart Veterinary Centers, a company operating specialty and emergency veterinary hospitals, from November 2007 to October 2009 and as the Chief Executive Officer of the National Commission on Veterinary Economic Issues, a nonprofit association supporting the animal health and veterinary industry, from January 2001 to October 2007. Previously, he served as the Chief Executive Officer of Cardiopet, Inc. and as a Divisional Vice President of IDEXX Laboratories, Inc. Mr. Rubin also founded the Veterinary Referral Centre, a comprehensive, multispecialty veterinary hospital since 2014.
Age | 71 |
Tenure | 11 years |
Professional Marks | MBA |
Address | 6100 4th Avenue South, Seattle, WA, United States, 98108 |
Phone | 855 727 9079 |
Web | https://www.trupanion.com |
Howard Rubin Latest Insider Activity
Tracking and analyzing the buying and selling activities of Howard Rubin against Trupanion stock is an integral part of due diligence when investing in Trupanion. Howard Rubin insider activity provides valuable insight into whether Trupanion is net buyers or sellers over its current business cycle. Note, Trupanion insiders must abide by specific rules, including filing SEC forms every time they buy or sell Trupanion'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Howard Rubin over a month ago Disposition of 569 shares by Howard Rubin of Trupanion subject to Rule 16b-3 | ||
Howard Rubin over a month ago Disposition of 569 shares by Howard Rubin of Trupanion subject to Rule 16b-3 | ||
Howard Rubin over a month ago Disposition of 569 shares by Howard Rubin of Trupanion subject to Rule 16b-3 | ||
Howard Rubin over a month ago Disposition of 569 shares by Howard Rubin of Trupanion subject to Rule 16b-3 |
Trupanion Management Efficiency
As of 03/21/2025, Return On Tangible Assets is likely to drop to -0.01. In addition to that, Return On Capital Employed is likely to drop to -0.02. At this time, Trupanion's Total Current Liabilities is relatively stable compared to the past year. As of 03/21/2025, Liabilities And Stockholders Equity is likely to grow to about 847.2 M, while Non Current Liabilities Other is likely to drop slightly above 2.9 M. Trupanion's management efficiency ratios could be used to measure how well Trupanion manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Mohammad Yousaf | NMI Holdings | 48 | |
Robert CPA | Assured Guaranty | 59 | |
Andrew Wert | Investors Title | N/A | |
Allison Miller | NMI Holdings | N/A | |
Elizabeth Wainio | Investors Title | N/A | |
Michael Hoffmann | James River Group | 60 | |
Elizabeth Lewter | Investors Title | N/A | |
Michael Derstine | Enact Holdings | 54 | |
Gon Chow | Assured Guaranty | 54 | |
Neenu Kainth | Enact Holdings | N/A | |
Manuel Becerra | Assurant | 60 | |
Benjamin Rosenblum | Assured Guaranty | 51 | |
Matthew Young | Enact Holdings | N/A | |
John Herath | Investors Title | N/A | |
Danny GarciaVelez | MGIC Investment Corp | N/A | |
Patrick John | Investors Title | N/A | |
Harris Susan | Investors Title | N/A | |
Sarah Doran | James River Group | 52 | |
Claude Sarfo | Assurant | N/A | |
Joseph III | Assurant | N/A | |
David Buzen | Assured Guaranty | 65 |
Management Performance
Return On Equity | -0.0441 | |||
Return On Asset | -0.0072 |
Trupanion Leadership Team
Elected by the shareholders, the Trupanion's board of directors comprises two types of representatives: Trupanion inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Trupanion. The board's role is to monitor Trupanion's management team and ensure that shareholders' interests are well served. Trupanion's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Trupanion's outside directors are responsible for providing unbiased perspectives on the board's policies.
Fawwad Qureshi, Chief Officer | ||
Gavin Friedman, Exec Sec | ||
Andrew MBA, Chief Officer | ||
Scott Janzen, Director Communications | ||
John Gallagher, Executive Services | ||
Christopher Kearns, Chief Officer | ||
Brenna McGibney, Chief Officer | ||
Tricia Plouf, Chief Officer | ||
Margaret Tooth, Chief Marketing Officer | ||
MRCVS BVMS, Executive Strategy | ||
Bradley Lamb, Head Conversion | ||
Emily Dreyer, Insights Planning | ||
Wei Li, Senior Controller | ||
Chris Cappelletti, CTO Data | ||
Mary Rothlisberger, Head Insights | ||
Howard Rubin, Independent Consultant | ||
Laura Bainbridge, Senior Communications | ||
Darryl Rawlings, Founder, CEO and President and Director | ||
Asher Bearman, General Counsel and Secretary | ||
Shawn McWashington, Head Benefits | ||
Steve Ireland, Senior Marketing |
Trupanion Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Trupanion a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.0441 | |||
Return On Asset | -0.0072 | |||
Profit Margin | (0.01) % | |||
Operating Margin | 0.01 % | |||
Current Valuation | 1.42 B | |||
Shares Outstanding | 42.34 M | |||
Shares Owned By Insiders | 13.87 % | |||
Shares Owned By Institutions | 86.13 % | |||
Number Of Shares Shorted | 9 M | |||
Price To Book | 4.95 X |
Additional Tools for Trupanion Stock Analysis
When running Trupanion's price analysis, check to measure Trupanion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trupanion is operating at the current time. Most of Trupanion's value examination focuses on studying past and present price action to predict the probability of Trupanion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trupanion's price. Additionally, you may evaluate how the addition of Trupanion to your portfolios can decrease your overall portfolio volatility.